FRIDAY 27 MARCH - PROGRAM Time PROMENADE ROOM 1 & 2 Joint Session | Sponsored by Berlinger Emerging Risks and Opportunities Chair: Mary Robinson 8:30AM Mimicking metabolism –exploiting organ-on-a-chip options for drug biotransformation studies Prof Mario Thevis 8:50AM Tracking Fairness: Intelligence-Based Anti-Doping Efforts Dr Vanessa Agon 9:10AM Meeting the Challenge of Gene Doping in Animal and Human Sports Dr Natasha Hamilton 9:30AM From Stable to Stadium: Cross-Species Synergies Shaping the Future of Anti-Doping Dr Tessa Muir 10:30AM Morning Tea PROMENADE ROOM 1 & 2 PROMENADE ROOM 3 Analytical Session Molecular Biology Chair: Mario Thevis Veterinary Session Injury Prevention Chair: Sally Taylor 10:55AM Routine Implementation of ISO-accredited Screening and Confirmatory Methods for Transgene Detection in Horses Edward Ryder A Genomic Prediction Model for Risk of Catastrophic Fracture of the Distal Limb/Fetlock in US Thoroughbreds Mary A Robinson 11:15AM Overview and Future Perspectives on Gene Doping and Genome Editing Detection in Japan Teruaki Tozaki Genetic Risk Factors for Musculoskeletal Injury in the Greyhound: Implications for Breeding and Welfare Madeleine L.H. Campbell 11:35AM Gene Editing Detection in Horses: Approaches to Screening and Confirmatory Validation for Accredited Testing Edward Ryder Transcriptomic Profiling of Pre-Race Whole Blood in Thoroughbreds with Race-Day Fractures Allen E Page 11:55AM DNA-Based Identification of Registered Horses, From Forensic Samples Natasha A Hamilton Computed Tomography Features of the Fetlock Joint in Elite Racing Thoroughbred Horses Cathy Beck 12:15PM firstFlagX: Improvements Toward Automation-Ready, ExtractionEnabled Bioactivity Screening Across Biological and Product Matrices Alison K Heather Correlation of Synovitis with Gross Osteochondral Lesions in the Joints of Racehorses Simon R Bailey 12:35PM Lunch Sponsored by Shimadzu PROMENADE ROOM 1 & 2 PROMENADE ROOM 3 Analytical Session Macromolecules Chair: Andrew McKinney Veterinary Session Regulation / General Interest Chair: William Farmer 1:25PM Administration Study of Somapacitan, a Long-acting Growth Hormone Derivative, in Horses and its Elimination in Equine Plasma for Doping Control Purposes Yoshibumi Shimizu Review of the Direct and Indirect Effects of the Horseracing Integrity and Safety Authority (HISA) During the First Three Years of Implementation at One U.S. Racetrack Ron Friedman XXXVIII ICRAV 2026
RkJQdWJsaXNoZXIy MTI3ODI1